Canestraro, M. Et Al. 2010. Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders. CANCER GENETICS AND CYTOGENETICS , vol.199, no.2 , 110-120.

Canestraro, M., Galimberti, S., SAVLI, H., Palumbo, G. A., Tibullo, D., Nagy, B., ... Guerrini, F.(2010). Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders. CANCER GENETICS AND CYTOGENETICS , vol.199, no.2, 110-120.

Canestraro, Martina Et Al. "Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders," CANCER GENETICS AND CYTOGENETICS , vol.199, no.2, 110-120, 2010

Canestraro, Martina Et Al. "Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders." CANCER GENETICS AND CYTOGENETICS , vol.199, no.2, pp.110-120, 2010

Canestraro, M. Et Al. (2010) . "Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders." CANCER GENETICS AND CYTOGENETICS , vol.199, no.2, pp.110-120.

@article{article, author={Martina Canestraro Et Al. }, title={Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders}, journal={CANCER GENETICS AND CYTOGENETICS}, year=2010, pages={110-120} }